Literature DB >> 8457603

Characterization of Ca(2+)-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni.

A A Siddiqui1, Y Zhou, R B Podesta, S R Karcz, C E Tognon, G H Strejan, G A Dekaban, M W Clarke.   

Abstract

Calcium-dependent, neutral cysteine-proteases (calpain) were purified from human blood flukes, Schistosoma mansoni. The electrophoretic mobilities, Western blot analyses and high specificity to peptide inhibitors confirmed the presence of both calpain I and II in the purified preparation. The schistosome calpains were localized in the surface syncytial epithelium and underlying musculature. Using peptide inhibitors, calpain was shown to function as a mediator of the surface membrane synthetic process. Since there was also no immunological cross-reactivity between vertebrate and schistosome calpains using antibodies affinity-purified from native and recombinant schistosome calpains, this protease may be usefully investigated as forming the basis of a molecular vaccine against schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457603     DOI: 10.1016/0925-4439(93)90087-h

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  38 in total

1.  Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models.

Authors:  Workineh Torben; Gul Ahmad; Weidong Zhang; Afzal A Siddiqui
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

2.  Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.

Authors:  Afzal A Siddiqui; Troy Phillips; Hugues Charest; Ron B Podesta; Martha L Quinlin; Justin R Pinkston; Jenny D Lloyd; Michelle Paz; Rachael M Villalovos; Janet Pompa
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

3.  Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice.

Authors:  Loc Le; Weidong Zhang; Souvik Karmakar; Gul Ahmad; Workineh Torben; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2014-01-23       Impact factor: 2.289

Review 4.  Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials.

Authors:  Afzal A Siddiqui; Sabrina Z Siddiqui
Journal:  Trends Parasitol       Date:  2016-11-16

5.  Immuno-evasive tactics by schistosomes identify an effective allergy preventative.

Authors:  Qyana Griffith; YanMei Liang; Patrick Whitworth; Carlos Rodriguez-Russo; Ahmad Gul; Afzal A Siddiqui; John Connor; Pauline Mwinzi; Lisa Ganley-Leal
Journal:  Exp Parasitol       Date:  2015-03-24       Impact factor: 2.011

6.  Solution structure, membrane interactions, and protein binding partners of the tetraspanin Sm-TSP-2, a vaccine antigen from the human blood fluke Schistosoma mansoni.

Authors:  Xinying Jia; Leigh Schulte; Alex Loukas; Darren Pickering; Mark Pearson; Mehdi Mobli; Alun Jones; Karl J Rosengren; Norelle L Daly; Geoffrey N Gobert; Malcolm K Jones; David J Craik; Jason Mulvenna
Journal:  J Biol Chem       Date:  2014-01-15       Impact factor: 5.157

7.  Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy.

Authors:  Weidong Zhang; Adebayo J Molehin; Juan U Rojo; Justin Sudduth; Pramodh K Ganapathy; Eunjee Kim; Arif J Siddiqui; Jasmin Freeborn; Souad R Sennoune; Jordan May; Samra Lazarus; Catherine Nguyen; Whitni K Redman; Gul Ahmad; Workineh Torben; Souvik Karmakar; Loc Le; Kameswara R Kottapalli; Pratibha Kottapalli; Roman F Wolf; James F Papin; David Carey; Sean A Gray; Jenn D Bergthold; Raymond T Damian; Bryan T Mayer; Florian Marks; Steven G Reed; Darrick Carter; Afzal A Siddiqui
Journal:  Ann N Y Acad Sci       Date:  2018-08       Impact factor: 5.691

8.  Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

Review 9.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 10.  Development of a schistosomiasis vaccine.

Authors:  Adebayo J Molehin; Juan U Rojo; Sabrina Z Siddiqui; Sean A Gray; Darrick Carter; Afzal A Siddiqui
Journal:  Expert Rev Vaccines       Date:  2016-01-13       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.